Bezafibrate Treatment for Bipolar Depression
Phase 2
30
about 8.1 years
18–65
1 site in MA
About this study
Researchers are testing whether bezafibrate, a medication, can help with bipolar depression. The trial will last 2970 days and involve monitoring changes in manic symptoms, suicidal thoughts, cognitive function, and adverse events. This proof-of-concept phase IIa trial aims to assess the safety and tolerability of bezafibrate added to anti-manic medication for bipolar depression.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Bezafibrate
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
bezafibrate
oral (Oral Tablet)
Primary: Change from Baseline to Week 8 in Montgomery-Åsberg Depression Rating Scale (MADRS)
Secondary: Change from Baseline to Week 8 in Clinical Global Impressions Bipolar Scale (CGI-BP-S) score
Psychiatry / Mental Health